Rudolf Prager - Concepedia

Author

Rudolf Prager

Also Known As

Bernhard Paulweber, Changyu Pan, Christoph Ebenbichler, Gaciong, Zbigniew, R Prager, R. PRAGER, R. Prager, RUDOLF PRAGER, Rudolf JF Prager, Rudolf PRAGER

192

Publications

10.4K

Citations

H-Index

Concepts

All Affiliations

Klinik Hietzing University of Vienna Medical University of Vienna Ludwig Boltzmann Institute for Digital Health and Prevention Karl Landsteiner Society

About

Rudolf Prager is an author at Klinik Hietzing specializing in diabetes, medicine, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	44	5.4K
2	Health Sciences	20	24	2.9K
3	Biochemistry	7	7	446
4	Public Health	4	4	720
5	Natural Sciences	1	1	10

Rudolf Prager

Publications

8.4K

Citations

H-Index

Page 1

	Year	Citations
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial Carel W. le Roux, Arne Astrup, Ken Fujioka, The Lancet ObesityMetabolic SyndromeNutritionDiabetes ManagementLiraglutide Versus Placebo	2017	813
Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. Richard N. Bergman, Rudolf Prager, Jerrold M. Olefsky Journal of Clinical Investigation Minimal Model ApproachEuglycemic Glucose ClampObesityMetabolic SyndromeInsulin Sensitivity Index	1987	777
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, The Lancet UrologyRenal DiseaseRenal EventsRenal FunctionDiabetes	2019	589
The Relative Benefits of Endurance and Strength Training on the Metabolic Factors and Muscle Function of People With Type 2 Diabetes Mellitus Edmund Cauza, Ursula Hanusch‐Enserer, Barbara Strasser, Archives of Physical Medicine and Rehabilitation Metabolic SyndromePhysical ActivityKinesiologyRelative BenefitsExercise	2005	390
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease Danilo Fliser, Giovanni Pacini, R. Engelleiter, Kidney International ObesityMetabolic SyndromeHypertensionUrologyRenal Disease	1998	355
PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease) M Huelsmann, Stephanie Neuhold, Michael Resl, Journal of the American College of Cardiology Diabetes ManagementCardiovascular DiseaseDiabetesDiabetic PatientsNt-probnp Selected Prevention	2013	340
Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus Andrea Griesmacher, Marlene Kindhauser, Sylvia Andert, The American Journal of Medicine Metabolic SyndromeDiabetesEnhanced Serum LevelsPhysiologyDiabetes Mellitus	1995	300
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial Paresh Dandona, Chantal Mathieu, Moshe Phillip, The Lancet Diabetes & Endocrinology Metabolic SyndromeType 1Diabetes ManagementHealth PolicyCardiovascular Disease	2017	286
Pronounced Insulin Resistance and Inadequate β-cell Secretion Characterize Lean Gestational Diabetes During and After Pregnancy Alexandra Kautzky‐Willer, Rudolf Prager, W. Waldhäusl, Diabetes Care	1997	208
In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. Rudolf Prager, Penny Wallace, Jerrold M. Olefsky Journal of Clinical Investigation Insulin Infusion RateInsulin SignalingObesityMetabolic SyndromeBody Composition	1986	201

Page 1